St. Michael's Dr. Sean B. Rourke receives federal funds for iHIV/AIDS research

December 04, 2012

TORONTO, Dec. 4, 2012--Dr. Sean B. Rourke, a psychologist who heads the Neurobehavioural Research Unit at St. Michael's Hospital, has received $1.5 million from the federal government for a community-based HIV/AIDS research centre.

Dr. Rourke is the lead and director for the CBR Collaborative Centre in HIV/AIDS, which will focus on building capacity to carry out innovative HIV/AIDS research across Canada.

This centre connects with and builds on his CIHR Centre for REACH in HIV/AIDS, a population health and health services. REACH is a national partnership among people living with HIV, community-based organizations, front-line service providers, health researchers from more than 25 academic institutions (over 250 members) across Canada, and federal, provincial, and regional policy makers.

The CBR Centre will also be linked with his Universities without walls, an education and training initiative funded by CIHR (STIHR) to support the next generation of HIV researchers in Canada.

His was one of only two community-based centres to receive federal funding in an announcement by Health Minister Leona Aglukkaq on Nov. 27. Another $1.5 million went to the Canadian Aboriginal AIDS Network to support the Aboriginal HIV and AIDS Community-Based Research Collaborative Centre, which will bring Aboriginal communities and researchers together to address specific challenges for Aboriginal Canadians.

The funding comes from the Canadian Institutes of Health Research HIV/AIDS Research Initiative.

"Our CBR centre will mobilize and inspire regional teams of researchers and community-based agencies across the country," Dr. Rourke said.

"Grounded in their regions, these teams will conduct relevant, rigorous research that will respond to local issues and needs. The findings will lead to better interventions and services for people living with or at risk of HIV, enhancing their health and well-being. At the national level, the centre will build healthier communities and further our efforts to get ahead of the HIV epidemic by bringing regional teams together into a network that will learn from one another, share their findings, build on each other's knowledge, and transfer and adapt successful interventions from one region to another."
-end-
About St. Michael's Hospital

St. Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in more than 23 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, and care of the homeless are among the Hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Center, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

For more information or to interview Dr. Rourke, please contact:

Leslie Shepherd
Manager, Media Strategy
St. Michael's Hospital
Inspired Care. Inspiring Science.
www.stmichaelshospital.com


Follow us on Twitter:http://www.twitter.com/stmikeshospital

St. Michael's Hospital

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.